SPRY

Companies
NASDAQ
Ars Pharmaceuticals Inc
Health Care
Price Chart
Overview

About SPRY

silverback therapeutics is a biotechnology company that was founded in 2016. the company is based in seattle, wa and is funded by orbimed.

Market Cap
$853.6M
Volume
25.2M
Avg. Volume
23.9M
P/E Ratio
-18.157896
Dividend Yield
0.00%
Employees
23.0

Company Information

Exchange
NASDAQ
Sector
Health Care
Industry
Biotechnology
Risk & Correlation Analysis
Market Correlation
0.67
Low Correlation
Volatility
High (0.65)
Relative to market

Macro Factor Sensitivities

Interest Rates
Medium Sensitivity
Inflation
Medium Sensitivity
GDP Growth
Low Sensitivity
Liquidity
Medium Sensitivity
Commodity Prices
Low Sensitivity
Credit Quality
Medium Sensitivity
Portfolio Impact
Forecasts & Predictions

Premium Forecasts

Get AI-powered price predictions, technical analysis, and market forecasts for SPRY.

1-Month Target
$XXX.XX
+X.X% Potential
3-Month Target
$XXX.XX
+X.X% Potential
12-Month Target
$XXX.XX
+X.X% Potential

Technical Analysis

Based on technical indicators and chart patterns, SPRY shows...

AI Sentiment Analysis

Market sentiment analysis indicates...

Key Statistics
Market Cap$853.6M
Volume25.2M
P/E Ratio-18.16
Dividend Yield0.00%
Important Dates
Next Dividend
Next Earnings
May 14, 2025

PortfolioPilot Analysis

Get AI-powered insights on how SPRY fits into your investment strategy and portfolio diversification.

Pricing info last updated June 18, 2025 (after market close)Other info last updated April 2, 2025